Dr. Patricia Moore PhD Facebook ad: “They Treated Symptoms, Not Cause”

About this ad

Meta Ad Library ID

1356942026268345

Platforms

Facebook, Instagram, Audience Network, Messenger and Threads

Relaunches

0

Niche

Coaching & Personal Growth

How we count

Ad text

My mother took hormone replacement therapy for nine years. Her hormone levels were balanced at every single checkup. When she died from complications of the cognitive decline her doctors attributed to “post-menopausal aging” at sixty-seven, I asked her gynecologist how that was possible if the hormones were always in range. What she told me changed everything I thought I knew about what perimenopause actually does. Because six months ago, I was standing in the same spot my mother stood. Same labs on the desk. Same doctor ready to write the same prescription. And I almost accepted it without asking the question that would have saved my mother’s life. My bloodwork showed estradiol declining, FSH elevated, cortisol high. My doctor didn’t hesitate. “You’re in perimenopause. I’d like to start you on low-dose HRT and something for the anxiety component.” Eight minutes. That’s how long the appointment lasted. She read the labs, explained the transition, and told me this was “what most women your age need.” But my brother works in functional and integrative medicine and he wouldn’t let it go. “Your doctor checks whether your hormone levels are in range,” he said. “That’s a number on a panel. A functional medicine specialist checks what happens to your cells during the hormonal transition — specifically the oxidative stress surge that fires when estrogen’s natural antioxidant protection drops. Those are two completely different things. Before you start HRT, I want someone checking what’s actually happening at the cellular level.” The specialist spent fifty minutes with me. Not eight. She ran tests my regular doctor had never ordered — oxidative stress panel, mitochondrial function assessment, hydroxyl radical load, cellular ATP output, and an estrogen-oxidative interaction profile. She checked things my mother’s gynecologist had never run in nine years of managing her “post-menopausal maintenance.” When she came back with the results, she wasn’t smiling. “Your labs show declining estradiol and elevated FSH. That tells me one thing — you’re in perimenopause. But these other tests tell me something your hormone panel can’t.” She turned the screen toward me. Graphs. Color-coded charts. Cellular data. “This is your oxidative stress load. The hydroxyl radical activity that your estrogen was suppressing — its natural antioxidant function that protected your mitochondria, your neural tissue, your cardiovascular system from free radical damage for three decades.” She pointed at a range on the chart. “A woman with stable estrogen should have an oxidative load in this range.” She pointed at another range. Much higher. “You’re here. And your estrogen has been declining for less than two years. Your cells have been losing that estrogen-driven protection for longer — but the surge you’re experiencing now is the body’s natural defense coming offline.” I stared at her. “But my doctor said HRT would restore my estrogen levels. If the hormones are back in range—” “The HRT replaces the estrogen molecules,” she said. “But the oxidative damage your cells have been accumulating during the transition — the surge that fired when your natural protection dropped — that has been running for longer than the hormone levels reflect. And for many women, restoring hormone levels doesn’t fully restore the antioxidant protection that was lost during the transition period.” She let that settle. “Think about it. Your symptoms didn’t start the day your FSH spiked. The brain fog came first. Then the fatigue at two PM that used to never happen. Then the sleep that stopped being restorative. Your doctor watched the symptoms accumulate and attributed them to hormonal transition. Then she reached for HRT.” “But what was happening inside your mitochondria during those years? The oxidative damage was already well underway. The cellular depletion I’m measuring today didn’t start when your labs showed declining estradiol. It started when your estrogen protection first began to fluctuate — years before the number crossed a diagnostic threshold.” “Your hormone panel is the surface,” she said. “What I’m seeing at the cellular level is years ahead of what those numbers suggest.” I felt sick. “So what does the HRT do?” She was direct. “HRT restores circulating estrogen to a target range. Hormonal symptoms improve — hot flashes reduce, mood stabilizes somewhat. Your doctor sees improved symptom scores and says ‘the HRT is working, continue.’” She paused. “But it doesn’t automatically restore the mitochondrial function that was damaged during the oxidative surge. It doesn’t rebuild cellular ATP production. It doesn’t repair the neural tissue that accumulated free radical damage while the estrogen protection was fluctuating. Hormone levels improve on paper. The cellular energy deficit — what I’m measuring on these tests — can persist independently of where the hormone number lands.” She looked at me. “HRT for hormonal oxidative damage is like refilling the gas tank while the engine is corroding. The gauge reads full. The engine doesn’t know.” And that’s when I understood what happened to my mother. She’d been on HRT for nine years. Started at fifty-four — low-dose patch, then adjusted upward. Her gynecologist called it “the most evidence-based approach to post-menopausal management.” Said it was safe. Protective. She’d probably need it indefinitely. The symptom relief came within three months. Not dramatic. Gradual. Hot flashes decreased. Sleep improved slightly. Her doctor said “see? The HRT is working.” Year two, still tired. Doctor added a low-dose antidepressant. “For mood support during the transition.” Year three, memory issues. “That’s normal with hormonal changes. The HRT will help stabilize.” Year four, she started writing everything down because she couldn’t trust her recall. Her gynecologist referred her to her internist. The internist said her cognition was “within normal age-related range.” Year six, she got lost driving to a pharmacy she’d used for twenty years. My father started driving her everywhere. Her doctors — gynecologist, internist, neurologist — each saw their own piece. Nobody coordinated. Hormone levels: managed. Mood: managed. Cognition: “monitoring.” And the quality of life. God, the quality of life. This was a woman who had managed a household, four children, a part-time career, and the social calendar of a small community for forty years. Who remembered every birthday, every preference, every detail of every conversation she’d had with you in the last decade. By fifty-eight on HRT, she’d stopped reading because she couldn’t retain what she’d read from one page to the next. By sixty, she didn’t host anymore because managing the logistics felt overwhelming. By sixty-two, she sometimes called me by my sister’s name. The fear ate her alive. “My hormone levels are fine,” she’d say. “My doctor says everything is in range. Why can’t I think straight?” I remember visiting her. The books on the nightstand — same page bookmarks from months ago. The birthday cards she used to send everyone in the family — stopped. The way she’d reach for a word and it wouldn’t come, and she’d look at you with an apology in her face. Year eight, formal cognitive assessment. Mild cognitive impairment. Her neurologist said it was “consistent with post-menopausal aging patterns, not necessarily disease.” Year nine, she fell. Hip fracture. Surgery. The cognitive fog worsened significantly with the hospital stay and anesthesia. She never recovered baseline. She died at sixty-seven. Nine years of managed hormone levels. Estradiol always in range. And the cognitive erosion had been running the entire time. I told the specialist. She was quiet. “That’s unfortunately common,” she said. “The HRT restored her circulating estrogen. Her hormone numbers looked managed. But the oxidative damage to her neural tissue and mitochondria — which started accumulating when the estrogen protection first began to fluctuate — continued independent of what the hormone level showed on the panel. The numbers looked right. The cells kept losing function underneath. That’s the gap HRT can’t close.” There it was. The answer to the question I’d carried since I was thirty-five, watching my brilliant, detail-oriented mother slowly stop being the version of herself I’d always known. Her hormone levels were in range for nine years. And the thing that killed her kept advancing regardless. Now a specialist was telling me why. “So what do I do?” I asked. “Is HRT the only option?” She said I had two paths. Path one: Start the HRT. Hormone levels improve. Hormonal symptoms decrease. “But the oxidative damage to your mitochondria and neural tissue that fired during the transition continues independent of the hormone number,” she said. “And over time, cognitive and cellular function declines while everyone looks at the hormone panel and says the treatment is working.” Path two: Actually address the oxidative surge that fired when your estrogen protection dropped. “How?” I asked. She explained: Estrogen is not just a reproductive hormone. For thirty years, it acted as one of your body’s primary antioxidant shields — suppressing hydroxyl radical activity in your mitochondria and neural tissue. When estrogen begins to fluctuate during perimenopause, that shield comes offline. In some women, the surge of oxidative stress that follows is significant — measurable on cellular panels even when the hormone level itself appears “normal” by standard lab ranges. HRT replaces the molecule. It does not always fully restore the antioxidant function — especially the mitochondrial protection — that was lost during the fluctuation period. “HRT restores circulating estrogen,” she said. “But it doesn’t neutralize the hydroxyl radicals that have been damaging your mitochondria and neural tissue since the protection first dropped. It doesn’t rebuild cellular ATP production. The hormone level looks right. The oxidative damage at the cellular level continues. And your cognitive and physical function keeps declining while everyone looks at the panel and says you’re properly managed.” “Your mother had ‘in-range’ hormone levels for eight years on HRT,” she said. “Her estradiol was controlled. Her mitochondria kept losing output. Her neural tissue kept accumulating damage. The medication was managing the hormone number. It wasn’t protecting the cells.” Managing. Not protecting. That’s what my mother was for nine years on HRT. “Is there a way to actually address the oxidative surge?” I asked. She said the most effective compound for neutralizing hydroxyl radical activity in female patients going through hormonal transition — and for protecting mitochondrial and neural tissue from the oxidative surge that fires when estrogen protection drops — is molecular hydrogen at 12 ppm, the concentration used in Japanese clinical research specifically involving female populations and showing fatigue reduction, cognitive improvements, and measurable anti-inflammatory effects independent of hormone level changes. I almost laughed. “Hydrogen water? My doctor wants me on HRT and an antidepressant and you’re telling me about a tablet?” She pulled up research. “Your mitochondria and neural tissue need protection from the oxidative stress that’s destroying them independent of where your estrogen number sits. Molecular hydrogen at 12 ppm — pharmaceutical grade — is what the female-population studies used. Japan, where hydrogen therapy is most clinically advanced, has run the largest body of human research, including trials specifically in women, showing improvements in fatigue markers, inflammatory cytokines, and cognitive function. And because hydrogen is the smallest molecule in existence, it reaches mitochondria and neural tissue directly — including inside the brain — where your hormone replacement cannot guarantee protection.” “It’s the same goal HRT aims at — protecting your cells from the consequences of hormonal change. But HRT restores the hormone. Hydrogen neutralizes the oxidative destruction that was already running before the hormone level even dropped to a diagnostic threshold.” But — she held up a finger — most hydrogen products are completely useless for this. Weak formulations. 0.5 to 2 ppm. The clinical research used 12 ppm pharmaceutical-grade with mineral co-factors for cellular and neural delivery. And the tablet has to dissolve fast — hydrogen escapes in minutes if dissolution is slow. She said most products on the market are the cellular equivalent of 1 ppm when you need 12. The therapeutic concentration never reaches the tissue. So I started researching. Most were garbage. Underdosed. Wrong format. First brand — Amazon, top-rated. Six weeks. Slightly better mornings. Still foggy by two PM. Specs: 1.3 ppm, slow-dissolve tablet. Second brand — women’s wellness subscription. Eight weeks. Still losing words mid-sentence. Only 2 ppm, seventeen-minute dissolution time — hydrogen mostly escaped. Third brand — supplement store, most expensive. Four weeks. Still exhausted. Still not myself. I was out of time. My follow-up with my doctor was three weeks away. She was going to ask if I’d started the HRT. After the third brand failed, I found Hydroliv. 12 ppm pharmaceutical-grade molecular hydrogen. Mineral-based effervescent formula. Third-party tested. NSF certified. Certificate of Analysis published. One tablet every morning. I did not start the HRT. First two weeks: I tracked everything. Still some brain fog in the afternoons. But something was different — the 3 AM waking that had been disrupting my sleep for eight months happened less. Something was quieter underneath. Week three: I had a whole conversation at dinner without losing a word. It sounds ridiculous. But that was months since that had happened without a pause where the word used to be. My husband noticed before I said anything. Not the words. The pace. “You’re keeping up with everything today,” he said. “You haven’t stopped to search for something.” He was right. The slight searching quality that had crept into my speech over two years — gone. Just gone. Week four: I slept through to six AM. Woke up wanting to get up. Not dragging myself out. I sat at the kitchen table and cried. Relief, not sadness. The specific relief of recognizing yourself. Week six — labs before my follow-up. Oxidative stress panel: hydroxyl radical load down 49% from baseline. Mitochondrial output: up from 31st to 54th percentile. Inflammatory markers — CRP, IL-6 — both in normal range. My doctor reviewed the labs. Previous panel, four months prior: declining estradiol, elevated FSH, elevated cortisol, inflammatory markers elevated. HRT and antidepressant recommended. Today: Inflammatory markers normalized. Cortisol in range. Oxidative stress panel — which she hadn’t ordered, I’d gotten independently — showing significant cellular improvement. “You started the HRT?” “No.” Her head came up. “No?” “Molecular hydrogen. 12 ppm pharmaceutical-grade. It operates independently of hormone levels — neutralizes the oxidative surge directly rather than trying to replace the protection that dropped.” Long silence. “These inflammation numbers are not what I would expect from someone in active perimenopause without hormonal support. If this holds, I want to see you in four months. Continue what you’re doing.” I walked out. Called my brother. “Inflammation markers normalized. Oxidative stress down forty-nine percent. No HRT. She said continue.” He exhaled. “You addressed the actual surge.” “I addressed the actual surge.” Two weeks later, back to the specialist. She reran the cellular panel. Mitochondrial output: 62nd percentile. Hydroxyl radical load: near-normal range. Cognitive function assessment: measurably improved from baseline. She looked at the results. Then at me. “Your cellular markers are moving in a direction that would protect the neural and mitochondrial tissue your mother lost. Not just hormonal symptom management — the oxidative environment your cells are living in is changing. This is what protection looks like during a hormonal transition, not just number management.” Not management. Protection. That was five months ago. My brain this morning? I have words when I reach for them. I read a full chapter last night and remembered what happened in it. I’m in a meeting and I’m tracking the whole thread — not just catching pieces and guessing. Latest panel: oxidative stress markers in normal range for women without hormonal disruption history. Mitochondrial output: 71st percentile. Last month I hosted dinner. First time in over a year — I hadn’t trusted myself to manage the logistics without losing pieces of it. Twelve people. My mother’s lamb recipe. Everything came out right, on time, nothing forgotten. I looked around the table and recognized myself in the room. My mother never got that back. She spent nine years with hormone levels in range while nobody checked what the oxidative surge was doing to the cells those hormones used to protect. The specialist told me that if I had started the HRT and stopped there — managing the hormone number while the cellular damage continued — I would be following the trajectory she sees in most patients with my initial cellular presentation. “Your mother’s story isn’t unusual,” she said. “It’s the standard outcome when you replace the hormone without addressing the oxidative damage that fired when it dropped.” My mother replaced hormones for nine years. Estradiol in range. Progressive neural and cognitive deterioration. Died at sixty-seven. I neutralized the oxidative surge. In five months my cellular markers are healthier than they’ve been in a decade. If you’re reading this, you’re where I was. Perimenopause confirmed or suspected. Foggy, exhausted, losing words, sleeping poorly. Your doctor wants you on HRT. Maybe you’ve started it. Maybe it’s helped somewhat but not the way you hoped. Here’s what nobody told me until a specialist spent fifty minutes looking past the hormone panel: The brain fog and fatigue aren’t just hormonal. They’re the cellular consequence of the oxidative surge that fires when estrogen’s antioxidant protection drops during transition — a surge that standard bloodwork doesn’t measure and that hormone replacement doesn’t always fully address. Your mitochondria and neural tissue have been accumulating oxidative damage since the protection first fluctuated — probably years before your FSH crossed a diagnostic threshold. HRT restores circulating estrogen. It does not always restore the cellular function that was lost during the oxidative window that transition created. My mother proved where the management-only path leads. Hydroliv. 12 ppm pharmaceutical-grade molecular hydrogen. Mineral-based effervescent formula. Third-party tested. NSF certified. Certificate of Analysis at hydroliv.com. 60-day money-back guarantee. Track your cognitive sharpness — specifically: how often you lose words, how well you retain what you read, how you feel at 2 PM. When the searching stops, when the fog lifts — bring your oxidative stress panel to your doctor if she’ll run it. Let the cellular data make the argument. That’s what I did. My doctor saw inflammation and oxidative markers that told a different story than “active perimenopause without hormonal support.” She didn’t argue. She said “continue what you’re doing.” Cellular data doesn’t argue. Don’t wait until nine years on managed hormone levels has taken the cognitive tissue you can’t rebuild. Don’t follow the same road my mother followed. She managed the hormone number. I protected the cells. hydroliv.com P.S. — I noticed the 3 AM waking stopping by week two. I had a fog-free afternoon at week three. My specialist confirmed cellular protection at week six. Your timeline will vary — but the 60-day guarantee means you risk nothing finding out. P.P.S. — My mother spent nine years on HRT. Hormone levels in range. Progressive cognitive and cellular deterioration. Died at sixty-seven from what the managed numbers never once addressed. A specialist showed me the gap. Five months later, my cellular markers are in normal range. No HRT. Just the oxidative protection my cells were missing when the estrogen shield dropped. hydroliv.com

Where the ad sends people

hydroliv.com

They Treated Symptoms, Not Cause

Hydroliv